Cargando…

Breath-Based Diagnosis of Invasive Mucormycosis (IM)

BACKGROUND: Timely diagnosis of IM remains a major challenge in clinical mycology. Because of the lack of specific diagnostic methods for IM and the frequently fulminant nature of this infection, IM-associated mortality remains high. METHODS: We examined breath volatile metabolite profiles in a neut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koshy, Seena, Ismail, Nour, Astudillo, Carmen Leon, Haeger, Christina Mallarino, Aloum, Obadah, Acharige, Mahesh Thalavitiya, Farmakiotis, Dimitrios, Baden, Lindsey R, Marty, Francisco M, Kontoyiannis, Dimitrios P, Fredenburgh, Laxura, Koo, Sophia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632059/ http://dx.doi.org/10.1093/ofid/ofx162.124

Ejemplares similares

2134. Differential Changes in Breath Volatile Metabolites to Identify Carbapenem-Resistant Enterobacteriaceae (CRE) in a Murine Pneumonia Model
por: Ismail, Nour, et al.
Publicado: (2019)

2365. Volatile Metabolite-Based Detection of Clostridium difficile Infection (CDI)
por: Aloum, Obadah, et al.
Publicado: (2019)

Diet Modification and Metformin Have a Beneficial Effect in a Fly Model of Obesity and Mucormycosis
por: Shirazi, Fazal, et al.
Publicado: (2014)

Disseminated Mucormycosis with Positive Aspergillus Galactomannan
por: Kitmiridou, Despoina, et al.
Publicado: (2018)

Therapy of Mucormycosis
por: Sipsas, Nikolaos V., et al.
Publicado: (2018)

Mucormycosis of the Central Nervous System
por: Chikley, Amanda, et al.
Publicado: (2019)

Mucormycosis in 2023: an update on pathogenesis and management
por: Alqarihi, Abdullah, et al.
Publicado: (2023)

A Potential Explanation of a Positive Serum β-Glucan Assay in Mucormycosis
por: Kontoyiannis, Dimitrios P.
Publicado: (2016)

Drug-Resistant Candida glabrata Infection in Cancer Patients
por: Farmakiotis, Dimitrios, et al.
Publicado: (2014)

711. A Unique Breath Secondary Metabolite Volatile Signature for the Diagnosis of Histoplasmosis
por: Leon, Armando R, et al.
Publicado: (2021)

When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
por: John, Teny M., et al.
Publicado: (2021)

Are Unique Regional Factors the Missing Link in India’s COVID-19-Associated Mucormycosis Crisis?
por: Skaria, Jessy, et al.
Publicado: (2022)

Frequent False-positive Bronchoalveolar Lavage Galactomannan Values in a Real-world Setting
por: Le, Audrey, et al.
Publicado: (2017)

Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA
por: Jung, Dong Sik, et al.
Publicado: (2015)

Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma
por: Walsh, Thomas J., et al.
Publicado: (2019)

Fatal Mucormycosis and Aspergillosis in an Atypical Host: What Do We Know about Mixed Invasive Mold Infections?
por: Tsikala-Vafea, Maria, et al.
Publicado: (2020)

Impact of Hyperglycemia and Diabetes Mellitus on Breakthrough Mucormycosis Outcomes in Patients with Hematologic Malignancies—Complex and Intriguing Associations
por: Franklin, Alexander, et al.
Publicado: (2022)

2032. Predictors of 6-Week Mortality in Patients with Positive Bronchoalveolar Lavage (BAL) Galactomannan (GM)
por: Weiss, Zoe, et al.
Publicado: (2018)

710. Comparison of Initial CXR to CT in Patients (pts) with Hematologic Malignancy (HEM) and Documented Symptomatic Pulmonary Mucormycosis (PM)
por: Franklin, Alexander, et al.
Publicado: (2021)

Taking a Closer Look: Clinical and Histopathological Characteristics of Culture-Positive versus Culture-Negative Pulmonary Mucormycosis
por: Spallone, Amy, et al.
Publicado: (2022)

848. Discordant Chest Radiography and Computed Tomography Findings in Patients with Hematologic Malignancy and Invasive Mucormycosis: What Are the Prognostic Implications?
por: Wurster, Sebastian, et al.
Publicado: (2023)

Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study
por: Kontoyiannis, Dimitrios P., et al.
Publicado: (2016)

Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer
por: Axell-House, Dierdre B., et al.
Publicado: (2021)

Green Herring Syndrome: Bacterial Infection in Patients With Mucormycosis Cavitary Lung Disease
por: Peixoto, Driele, et al.
Publicado: (2014)

255. Breakthrough Mucormycosis (BT-MCR) on Antifungals Having Mucorales Activity Portrays Worse Prognosis compared with BT-MCR on Mold-Active Antifungals with no Mucorales Activity
por: Axell-House, Dierdre B, et al.
Publicado: (2019)

Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis
por: Wurster, Sebastian, et al.
Publicado: (2022)

2082. Using a Commercially Available Assay Measuring Cytomegalovirus (CMV)-Specific CD4+ and CD8+ T-Cell Immunity by Intracellular Cytokine Staining to Predict Clinically Significant CMV Events
por: Rogers, Ralph, et al.
Publicado: (2018)

Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept
por: Guermazi, Dorra, et al.
Publicado: (2023)

Virulence profile: Dimitrios P Kontoyiannis
por: Kontoyiannis, Dimitrios P
Publicado: (2013)

An Avid Imitator
por: Farmakiotis, Dimitrios, et al.
Publicado: (2016)

Pruritic Rash in a Patient with Hodgkin's Lymphoma
por: Le, Audrey, et al.
Publicado: (2018)

Gastric mucormycosis with splenic invasion a rare abdominal complication of COVID-19 pneumonia
por: Yuvaraj, M., et al.
Publicado: (2021)

Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
por: Rogers, Ralph, et al.
Publicado: (2020)

Correction to: Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
por: Rogers, Ralph, et al.
Publicado: (2020)

Relapsing EBV encephalitis in a renal transplant recipient
por: Stone, Joshua A., et al.
Publicado: (2017)

Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR
por: Pelcovits, Ari, et al.
Publicado: (2021)

39. Anti-Spike Monoclonal Antibody Therapy for Kidney Transplant Recipients with COVID-19
por: Hardesty, Anna, et al.
Publicado: (2021)

1298. High Prescription Rate of Medications with Significant Rifampin Drug Interactions in Patients with Diabetic Foot Osteomyelitis: Should Rifabutin be Included in Clinical Trials for Adjunctive Therapy?
por: Mallarino-Haeger, Christina, et al.
Publicado: (2023)

Mitochondrial Respiratory Pathways Inhibition in Rhizopus oryzae Potentiates Activity of Posaconazole and Itraconazole via Apoptosis
por: Shirazi, Fazal, et al.
Publicado: (2013)

Heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against Scedosporium prolificans via induction of apoptosis
por: Shirazi, Fazal, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vdisff65617733hpgj6uhg4e72